[1]
“Thymoquinone and chemoresistance in non-small cell lung cancer: Preclinical promise or therapeutic potential?”, J Curr Biomed Rep, vol. 6, no. 1, pp. 27–28, Mar. 2025, doi: 10.61882/jcbior.6.1.285.